Andrew Quick - 06 Jun 2023 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Chief Technology Officer
Signature
/s/ Donna Shiroma, by power of attorney
Issuer symbol
RCEL
Transactions as of
06 Jun 2023
Transactions value $
$0
Form type
4
Filing time
08 Jun 2023, 16:37:39 UTC
Previous filing
06 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +60K $0.00 60K 06 Jun 2023 Common Stock 60K $14.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date.